“…The rationale of using in vitro (and in vivo) nano/microarchitectural features to control cell fate (and neotissue growth) is based on the fact that cells naturally reside within a multifaceted, in this case architecturally speaking, ECM milieu. [139,140] Over the years, methods like nano/microimprinting lithography, [141][142][143] reactive ion etching, [144,145] multibeam laser, [146][147][148] dry etching, [149] hot embossing, [150,151] replica molding, [152] UV molding, [153] femtosecond laser irradiation, [154] and laser ablation [145] have been utilized to develop materials with even nanofeature fidelity that very closely imitate ECM supramolecular assemblies. Such technologies have allowed for the development of substrates with topographical features (e.g., grooves/ridges, pillars, wells) capable of eliciting feature (e.g., pattern [155] and feature size [156] ) dependent cell response (Table 2).…”